REQUEST A DEMO
Total
USD $0.00
Search more companies

Biosensors Interventional Technologies Pte. Ltd. (Singapore)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Secondary Activities: All Other Personal Services
Full name: Biosensors Interventional Technologies Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Biosensors Interventional Technologies Pte. Ltd. is engaged in manufacturing and marketing of medical devices used in interventional cardiology. The company offers drug-eluting stents, drug coated stents and bare metal stents as well as angioplasty catheters. Biosensors Interventional Technologies Pte. Ltd. operates as a subsidiary of Biosensors International Group, Ltd. The company was incorporated in 2006 and is based in Singapore.

Headquarters
36 Jalan Tukang, Singapore
Singapore; Singapore; Postal Code: 619266

Contact Details: Purchase the Biosensors Interventional Technologies Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Biosensors Interventional Technologies Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the Biosensors Interventional Technologies Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Biosensors Interventional Technologies Pte. Ltd. report to view the information.
Incorporation Date:
February 21, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Biosensors Indonesia Pte. Ltd.
Company Performance
Financial values in the chart are available after Biosensors Interventional Technologies Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
11.49%
Total operating revenue
11.49%
Net Profit (Loss) for the Period
-58.04%
Total assets
-5.18%
Total equity
-6.21%
Net Profit Margin
-7.55%
Return on Equity (ROE)
-4.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?